X

Trial Profile

A Two Part, Randomized Study of Dermacyte® Amniotic Wound Care Liquid for the Treatment of Non-Healing Venous Stasis Ulcers

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 03 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dermacyte liquid (Primary)
Indications Varicose ulcer
Focus Adverse reactions
Sponsors Merakris Therapeutics

Most Recent Events

10 Dec 2024 According to Merakris Therapeutics media release, company announced that enrollment is now open for Part 2 of its Phase 2 multicenter, clinical trial. Trial will enroll patients across approximately 10 medical centers in the United States with dosing to begin immediately. Company is targeting late-2025 for completion of the study.
10 Dec 2024 Planned number of patients changed from 40 to 50.
10 Dec 2024 Planned End Date changed from 31 Mar 2025 to 15 Oct 2025.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com